Member Info for KingHomerJ

Hellas.

I’m not sure you are understanding what Ian has stated.

INCE is effectively Gordon Dadds

GB bought Ince and rebranded GB as INCE.

Very easy to find out on google

As Ian pointed out they wouldn’t have this info

Money raised was to pay for acquisitions

Massive re rate on this.

As you correctly mentioned every company more or less issued the same message.

Should be easily get to 60p plus.

Plus 60p is only a 40mil MC ???

Only 69 mil shares in issue

Looking at charts Great.

45p is resistance then nothing above that.

The “shortfalls” in revenue Still do not justify the low MC when they are generating revenues of 100million plus

I can see this heading towards the 60p mark in the short term.

News next week should be positive directors purchased shares at 45p 4 months ago.

Only 69 million shares in issue.

Trading at £1.20 in Jan 2020

I can see some resistance at 45 then big gap to 60/70

MULTIBAGGER

Oh dear oh dear oh dear. Late to the game I presume.

Little more googling required haaaaaa

Not sure what you mean about results NOT being that good. Think you are way of the mark there pal.

Looking at 100Mil rev ?????????

Final results more likely next week imo previous RNS states Early July, that’s passing quickly.

Directors purchased shares worth 2 million at 45p 3 months ago.

£1+ December 2019

Only 96 million shares in issue

Role in results

Cloughster.

As Ian stated previous (thanks Ian)

The source is in the title.

Maybe you shouldn’t be investing.

All the best.

Adrian Biles, Group Chief Executive, commented:
“These strong results are a vindication of our strategy. They are the product of the new international platform we have developed under the Ince brand. We remain on track to deliver c.£100m of annualised revenue in the current financial year, even with political headwinds buffeting some key markets across the globe.
“The second half of the year traditionally provides the majority of the Group’s profits and the lateral appointments we have made will largely show through next year. The attractions of our model and approach are being recognised amongst senior lawyers and professionals in major financial markets around the globe as can be seen from the quality of our newest hires.
“I remain confident that the business can continue to develop from here generating increasing revenue and profits.”

Any day now - previous RNS states early July

Based on this comparison a similar sp & mc with 69 mil shares in issues is a sp of £2.00

30 p will be blown out the water - PYC is x100 better position than back then.

Short Term 50 Million MC would be still cheap

Roche AG‘s has paid US$30m upfront in a potential US$1.7bn deal to get access to Bicycle Therapeutics plc’s

Under the terms of the strategic agreement, Bicycle Therapeutics plc (Cambridge, UK; Lexington, US) will receive $30m upfront and could earn milestones cup to $1.7bn from Roche’s US branch Genentech.

Great news - Called this one :)

20 / 30 percent day incoming.

News rich few weeks Major Contract & Trading update as per previous years

Full funding of £150k published on NIHR site for Prostate Canacer Dosing application

PYC actively recruiting as of yesterday (stated in funding RNS for Major contract)

Directors bought in over subscribed fund raising.

Bicycle Therapeutics & Cancer Research UK update incoming who PYC are working with.

50 Million MC here we come for starters

Patience.

When PYC went on it’s 3000% rise a few years ago it was a similar situation. There was 30 days or something between first RNS and Contracts RNS

PYC historically also issues Trading updates this week or next.

All is well.